Establishes the "safeguarding reproductive care act" to maintain a stockpile of mifepristone and misoprostol for reproductive care access in New York.
The "safeguarding reproductive care act" establishes a stockpile of mifepristone and misoprostol to ensure continued access to reproductive care medications within the state. The commissioner is tasked with managing the stockpile, ensuring inventory management, physical security, and accounting of all drugs. The stockpile will be available to providers of reproductive health services, including emergency room providers and those funded under the reproductive freedom and equity grant program.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.